|
|
 |
News Article |
| US Expansion Plans, Institutional Investment and Changes to RHT Board |
April 20, 2006
|
Resonance Health Ltd today announced a funding and acquisition strategy to significantly expand its US business operations. The changes will include:
Intended acquisition of US based specialist pathology businesses
Intended institutional investment by a Queensland Investment Corporation Fund
Appointment of Dr Gary W. Pace, a current director of ResMed, Inc (NYSE:RND) and Peplin Ltd (ASX:PEP), as Chairman and changes to non-executive Directors
To view a copy of this ASX announcement please click on the investor link in the menu above and then ASX announcements. |
View all news articles |
|
